Cargando…

The use of bisphosphonates in the management of bone involvement from solid tumours and haematological malignancies – a European survey

Bone metastases in patients with solid tumours (ST) and bone lesions in patients with haematological malignancies (HM) are common. Associated skeletal‐related events (SREs) cause severe pain, reduced quality of life and place a burden on health care resources. Bone‐targeted agents can reduce the ris...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lebret, T., Casas, A., Cavo, M., Woll, P.J., Deleplace, C., Kennedy, C., Schoen, P., Jackisch, C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516244/ https://www.ncbi.nlm.nih.gov/pubmed/27072626 http://dx.doi.org/10.1111/ecc.12490

Ejemplares similares

Cancer Chemotherapy—Its role in the Treatment Strategy of Haematologic Malignancies and Solid Tumours
por: Crowther, D.
Publicado: (1977)

Targeting hypoxia in solid and haematological malignancies
por: Harris, Bill, et al.
Publicado: (2022)

Population pharmacokinetics of pevonedistat alone or in combination with standard of care in patients with solid tumours or haematological malignancies
por: Faessel, Hélène M., et al.
Publicado: (2019)

Comparison of epidemiological, clinical and microbiological characteristics of bloodstream infection in children with solid tumours and haematological malignancies
por: Garrido, M. M., et al.
Publicado: (2019)

Safety and efficacy of autologous tumour cell vaccines as a cancer therapeutic to treat solid tumours and haematological malignancies: a meta-analysis protocol for two systematic reviews
por: Khan, Sarwat T, et al.
Publicado: (2020)

PSYCHOLOGICAL ASPECTS OF HAEMATOLOGICAL MALIGNANCIES
por: Kulhara, P., et al.
Publicado: (1990)

The effect of anticancer therapy on anti-hepatitis B antibody titres in patients with haematological malignancies and solid tumours
por: Yilmaz, Bahiddin, et al.
Publicado: (2016)

Improving Bisphosphonate Infusion Monitoring at Haematology Medical Day Unit
por: Ong, Michal Wen Sheue, et al.
Publicado: (2017)

Activity of cyclosporins as resistance modifiers in primary cultures of human haematological and solid tumours.
por: Fridborg, H., et al.
Publicado: (1994)

Survival of critically ill patients with haematological malignancies compared with patients without haematological malignancy
por: Pugh, R, et al.
Publicado: (2013)

Cancer-Associated Thrombosis: A Clinical Scoping Review of the Risk Assessment Models Across Solid Tumours and Haematological Malignancies
por: Mosaad, Manar, et al.
Publicado: (2021)

Cytomegalovirus in Haematological Tumours
por: Alonso-Álvarez, Sara, et al.
Publicado: (2021)

Epithelial Mesenchymal Transition (EMT) and Associated Invasive Adhesions in Solid and Haematological Tumours
por: Greaves, David, et al.
Publicado: (2022)

Evolving prevalence of haematological malignancies in orphan designation procedures in the European Union
por: Polsinelli, Benedetta, et al.
Publicado: (2017)

Is intensive care beneficial for patients with haematologic malignancies?
por: Nyunga, M, et al.
Publicado: (2010)

Decreased blood histamine levels in patients with solid malignant tumours.
por: Burtin, C., et al.
Publicado: (1983)

Real-world use of denosumab and bisphosphonates in patients with solid tumours and bone metastases in Germany
por: Diel, Ingo, et al.
Publicado: (2020)

Preferred and actual place of death in haematological malignancies: a report from the UK haematological malignancy research network
por: Sheridan, Rebecca, et al.
Publicado: (2021)

Second primary malignancies in chronic lymphocytic leukaemia: Skin, solid organ, haematological and Richter's syndrome
por: Shen, Yandong, et al.
Publicado: (2021)

Tumour macrophages as potential targets of bisphosphonates
por: Rogers, Thea L, et al.
Publicado: (2011)

Tuberculosis in Patients with Haematological Malignancies
por: Anibarro, Luis, et al.
Publicado: (2014)

Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network
por: Smith, A, et al.
Publicado: (2011)

Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022
por: Snowden, John A., et al.
Publicado: (2022)

Treatment of malignant hypercalcaemia with aminohexane bisphosphonate (neridronate).
por: O'Rourke, N. P., et al.
Publicado: (1994)

Bisphosphonate Treatment of Benign Multifocal and Unifocal Osteolytic Tumours of Bone
por: Gibbons, C. L. M. H., et al.
Publicado: (2003)

European recommendations and quality assurance for cytogenomic analysis of haematological neoplasms
por: Rack, K. A., et al.
Publicado: (2019)

Haematological reference intervals of sows at end gestation in ten French herds, the impact of parity on haematological parameters and the consequences on reproductive performance
por: Boulbria, Gwenaël, et al.
Publicado: (2021)

Advances in the application of Raman spectroscopy in haematological tumours
por: Liang, Haoyue, et al.
Publicado: (2023)

Antiviral prophylaxis in patients with solid tumours and haematological malignancies—update of the Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO)
por: Sandherr, Michael, et al.
Publicado: (2015)

Expression of testicular genes in haematological malignancies
por: Lim, S H, et al.
Publicado: (1999)

Clinical use of rituximab in haematological malignancies
por: Avivi, I, et al.
Publicado: (2003)

The Role of miRNA in Haematological Malignancy
por: Gounaris-Shannon, Stephanie, et al.
Publicado: (2013)

Cancer stem cells in haematological malignancies
por: Zagozdzon, Radoslaw, et al.
Publicado: (2015)

Breast imaging findings in haematological malignancies
por: Glazebrook, K. N., et al.
Publicado: (2014)

The hypoxia signalling pathway in haematological malignancies
por: Irigoyen, Marta, et al.
Publicado: (2017)

The Application of CAR-T Cells in Haematological Malignancies
por: Skorka, Katarzyna, et al.
Publicado: (2020)

Clinical Proteomics of Biofluids in Haematological Malignancies
por: Dunphy, Katie, et al.
Publicado: (2021)

COVID-19 in children with haematological malignancies
por: Millen, Gerard Cathal, et al.
Publicado: (2022)

Immune-epigenetic crosstalk in haematological malignancies
por: Wong, Hera, et al.
Publicado: (2023)

Haematological malignancy on the ICU - can we identify survivors?
por: Shah, S, et al.
Publicado: (2001)

Cannot write session to /tmp/vufind_sessions/sess_sfi1c81g2e8fi2bv0cj8elacgp